Concepedia

Publication | Open Access

Effects of Metreleptin in Pediatric Patients With Lipodystrophy

DOIFull Paper Access

62

Citations

26

References

2017

Year

Rebecca J. Brown, Cristina Meehan, Elaine Cochran, Kristina I. Rother, David E. Kleiner, Mary Walter, Phillip Görden
The Journal of Clinical Endocrinology & Metabolism

Abstract

Metreleptin lowered A1c and triglyceride levels, and improved biomarkers of NAFLD in pediatric patients with lipodystrophy. These improvements are likely to reduce the lifetime burden of disease.

References

YearCitations

Page 1